Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (81-90 of 418) with videos related to

Pageof 42
Sort By:
Mycoses|October 13, 2017
Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungalsBerdieke Goemaere, Pierre Becker, Eric Van Wijngaerden, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2020
Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood samplingMatthias Gijsen, Johan Maertens, Katrien Lagrou, et al.
Medical Mycology Case Reports|January 2, 2023
Mucorales PCR in blood as an early marker of invasive gastrointestinal mucormycosis might decrease the delay in treatment: A case reportRobina Aerts, Greet De Vlieger, Yves Debaveye, et al.
Mycoses|November 3, 2010
Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould diseaseOliver A Cornely, Johan Maertens, Mark Bresnik, et al.
Medical Mycology|July 12, 2019
Antifungal drugs: What brings the future?Ruth Van Daele, Isabel Spriet, Joost Wauters, et al.
Haematologica|January 26, 2023
Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemiaCharlien Vandersmissen, Cristina Prieto, Olga Gielen, et al.
Critical Care (London, England)|November 10, 2020
Point of care aspergillus testing in intensive care patientsToine Mercier, Albert Dunbar, Vincent Veldhuizen, et al.
Respiratory Medicine Case Reports|September 6, 2021
A rare case of invasive pulmonary aspergillosis presenting as organizing pneumonia due to <i>Aspergillus niger</i> in an immunocompetent hostRaphaël Schils, Antoine Altdorfer, Filip Moerman, et al.
BMC Infectious Diseases|June 24, 2010
Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registryJohan Maertens, Gerlinde Egerer, Wan Shik Shin, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patientsKim Vanstraelen, Joost Wauters, Ine Vercammen, et al.
Pageof 42

Showing results (81-90 of 418) with videos related to

Sort By:
Pageof 42
Mycoses|October 13, 2017
Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungalsBerdieke Goemaere, Pierre Becker, Eric Van Wijngaerden, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2020
Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood samplingMatthias Gijsen, Johan Maertens, Katrien Lagrou, et al.
Medical Mycology Case Reports|January 2, 2023
Mucorales PCR in blood as an early marker of invasive gastrointestinal mucormycosis might decrease the delay in treatment: A case reportRobina Aerts, Greet De Vlieger, Yves Debaveye, et al.
Mycoses|November 3, 2010
Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould diseaseOliver A Cornely, Johan Maertens, Mark Bresnik, et al.
Medical Mycology|July 12, 2019
Antifungal drugs: What brings the future?Ruth Van Daele, Isabel Spriet, Joost Wauters, et al.
Haematologica|January 26, 2023
Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemiaCharlien Vandersmissen, Cristina Prieto, Olga Gielen, et al.
Critical Care (London, England)|November 10, 2020
Point of care aspergillus testing in intensive care patientsToine Mercier, Albert Dunbar, Vincent Veldhuizen, et al.
Respiratory Medicine Case Reports|September 6, 2021
A rare case of invasive pulmonary aspergillosis presenting as organizing pneumonia due to <i>Aspergillus niger</i> in an immunocompetent hostRaphaël Schils, Antoine Altdorfer, Filip Moerman, et al.
BMC Infectious Diseases|June 24, 2010
Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registryJohan Maertens, Gerlinde Egerer, Wan Shik Shin, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patientsKim Vanstraelen, Joost Wauters, Ine Vercammen, et al.
Pageof 42